AGENDA: DAY II
TUESDAY, JUNE 15, 2021
MORNING MINI SUMMITS
MINI SUMMITS ROUND II
MINI SUMMIT 6
Best Practices in Virtual Investigations10:00 am CET
Introductions, Panel Discussion and Q&A![](https://internationalpharmacongress.com/wp-content/themes/ipc/faculty/burn_100.jpg)
Keith Burn
Global Investigations Director, Ipsen Former Associate Investigator, Parliamentary and Health Service Ombudsman, NHS; Former Detective Constable, London Metropolitan Police, Slough, UK![](https://internationalpharmacongress.com/wp-content/themes/ipc/faculty/ennis_100.jpg)
Robert Ennis, JD, LLM
Vice President and Lead Compliance Counsel, Pfizer New York, NY, USA![](https://internationalpharmacongress.com/wp-content/themes/ipc/faculty/janorschke_100.jpg)
Franziska Janorschke
Global Head, Business Practices Office, Novartis International AG, Basel, Switzerland![](https://internationalpharmacongress.com/wp-content/themes/ipc/faculty/mcquillan_100.jpg)
Anthony McQuillan, LLB
Vice President Legal & Compliance EMEA, Medtronic International, London, UK![](https://internationalpharmacongress.com/wp-content/themes/ipc/faculty/giampetruzzi_100.jpg)
Gary F. Giampetruzzi, JD
Partner, Paul Hastings; Former Vice President and Assistant General Counsel, Head of Government Investigations, Pfizer Inc., New York, NY, USA (Discussion Coordinator)MINI SUMMIT 7: How to Build and Manage Healthcare Compliance Risk Assessments
10:00 am CET
Introductions, Panel Discussion and Q&A![](https://internationalpharmacongress.com/wp-content/themes/ipc/faculty/beasley_100.jpg)
Ann Beasley, JD
Chief Compliance Officer, Zai Lab; Former Senior Vice President, Chief Compliance Officer, Biogen; Former Global Compliance Office, Novartis Pharma AG, Boston, MA, USA![](https://internationalpharmacongress.com/wp-content/themes/ipc/faculty/dhalla_100.jpg)
Anisa Dhalla
Global Chief Compliance Officer, UCB, Inc., Atlanta, GA, USA![](https://internationalpharmacongress.com/wp-content/themes/ipc/faculty/egan_100.jpg)
Sue Egan
Director and Principal Consultant, Sue Egan Associates; Former Vice President Compliance, AstraZeneca, Great Missenden, Buckinghamshire, UK![](https://internationalpharmacongress.com/wp-content/themes/ipc/faculty/opar_100.jpg)
Lauri G. Opar
Head, Enterprise Risk Management & Risk Analytics Global Ethics & Compliance, GlaxoSmithKline Brentford, Middlesex, UK![](https://internationalpharmacongress.com/wp-content/themes/ipc/faculty/gallage-alwis_100.jpg)
Sylvie Gallage-Alwis, DEA, LLM
Partner, Signature Litigation Avocat à la Cour Solicitor in England & Wales Committees Vice Chair, International Association of Defense Counsel, Paris, France (Discussion Coordinator)MINI SUMMIT 8: Ethics and Compliance Issues when Interacting with Third Parties
10:00 am CET
Introductions, Panel Discussion and Q&A![](https://internationalpharmacongress.com/wp-content/themes/ipc/faculty/ducroquet_100.jpg)
Laetitia Ducroquet
Vice President, Global Business Ethics, Ipsen, Boulogne-Billancourt, France![](https://internationalpharmacongress.com/wp-content/themes/ipc/faculty/fell_100.jpg)
Alex Fell
Head Ethics, Compliance and DPO International, Amicus Therapeutics; Former Vice President, Global Ethics and Compliance, Head of Strategy, Planning and Operations, GlaxoSmithKline, London, UK![](https://internationalpharmacongress.com/wp-content/themes/ipc/faculty/korenchuk_100.jpg)
Keith Korenchuk, MPH, JD
Vice President and Chief Compliance Officer, DH Diagnostics, a Danaher Company, Chevy Chase, MD, USA![](https://internationalpharmacongress.com/wp-content/themes/ipc/faculty/nese_100.jpg)
Gina Nese, JD
Vice President Global Compliance and Ethics Officer, Align Technology; Former Chief Compliance Officer, Advanced Sterilization Products Bellevue, WA, USA![](https://internationalpharmacongress.com/wp-content/themes/ipc/faculty/prohasky_100.jpg)
Mario Prohasky
Principal, EMEA Compliance Consulting Lead, IQVIA, London, UK (Discussion Coordinator)MINI SUMMIT 9: Tech Enablement of Your Global Compliance Program
10:00 am CET
Introductions, Panel Discussion and Q&A![](https://internationalpharmacongress.com/wp-content/themes/ipc/faculty/abrahamson_100.jpg)
Matt Abrahamson, MBA
Senior Compliance Analyst, DH Diagnostics LLC, a Danaher company, Buffalo Grove, IL, USA![](https://internationalpharmacongress.com/wp-content/themes/ipc/faculty/gumpert_100.jpg)
Ethan Gumpert
Global Ethics, Compliance & Governance, Advanced Medical Technology Association (AdvaMed), Washington, DC, USA![](https://internationalpharmacongress.com/wp-content/themes/ipc/faculty/minassian_100.jpg)
Vahan Minassian, JD
Digital Compliance Counsel, Compliance Division, Global Programs, Pfizer, Philadelphia, PA, USA![](https://internationalpharmacongress.com/wp-content/themes/ipc/faculty/muscato_100.jpg)
Sharon Muscato
Director, Compliance Operations, Moderna; Former Director, Transparency & Compliance Operations, Alexion Pharmaceuticals, Inc.; Cambridge, MA![](https://internationalpharmacongress.com/wp-content/themes/ipc/faculty/westphal_100.jpg)
Vanessa Westphal, JD, MS
Head of Compliance Center of Excellence, Merck KGaA, Darmstadt, Germany![](https://internationalpharmacongress.com/wp-content/themes/ipc/faculty/esche_100.jpg)
Steffen Esche
Director, Consulting, Risk & Regulatory, PwC, Frankfurt, Germany (Discussion Coordinator)11:00 am CET
Transition BreakMINI SUMMITS ROUND III
MINI SUMMIT 10: Challenges and/or Considerations in Maintaining a Methodology in a Fair Market Value (FMV) Analysis
11:15 am CET
Introductions, Panel Discussion and Q&A![](https://internationalpharmacongress.com/wp-content/themes/ipc/faculty/dieners_100.jpg)
Peter Dieners, Esq.
Regional Managing Partner (Germany) and Head, Global Healthcare and Life Sciences Group, Clifford Chance; Member, Legal Affairs Focus Group and Compliance Network, MedTech Europe; Member, Legal Affairs Committee and Healthcare Compliance Committee, BVMed, Düsseldorf, Germany![](https://internationalpharmacongress.com/wp-content/themes/ipc/faculty/schmidt_100.jpg)
Pascale Schmidt
Chief Compliance Officer and Chair, Corporate Sustainability Committee, F. Hoffmann-La Roche Ltd, Basel, Switzerland![](https://internationalpharmacongress.com/wp-content/themes/ipc/faculty/teresi_100.jpg)
Heidi Teresi
Director, US Ethics & Compliance, Bausch Health; Former Lead, Education and Communication, US Compliance and Ethics, Bristol-Myers Squibb, Princeton, NJ![](https://internationalpharmacongress.com/wp-content/themes/ipc/faculty/bolesh_100.jpg)
Eric Bolesh
Chief Operating Officer, Cutting Edge Information, Raleigh-Durham, NC, USA (Discussion Coordinator)MINI SUMMIT 11: Ethics and Compliance Considerations for Gene Therapy and Ultra Rare Disease Products
11:15 am CET
Introductions, Panel Discussion and Q&A![](https://internationalpharmacongress.com/wp-content/themes/ipc/faculty/gonzales_100.jpg)
Sandra González, JD
Senior Associate, Life Sciences and Healthcare Practice Group, Paul Hastings, New York, NY, USA![](https://internationalpharmacongress.com/wp-content/themes/ipc/faculty/laymand_100.jpg)
Dominique Laymand, Esq.
Executive Vice President, Chief Ethics and Social Responsibility Officer, Ipsen Honorary President, International Society of Healthcare Ethics and Compliance Professionals (ETHICS), Paris, France![](https://internationalpharmacongress.com/wp-content/themes/ipc/faculty/pepe_100.jpg)
Piergiorgio Pepe, MA
EU Law, President, Quantum Ethics, Ethics and Compliance Lecturer, SciencesPo Board Member, Strategic Committee International Society of Healthcare Ethics and Compliance Professionals (ETHICS); Former Compliance Director Western Europe & Canada, AbbVie, Former Director, Compliance & Ethics EMEA, Bristol-Myers Squibb, Paris, France![](https://internationalpharmacongress.com/wp-content/themes/ipc/faculty/vincze_100.jpg)
Steve Vincze, JD, LLM, MBA
President and Chief Executive Officer, TRESTLE Compliance, LLC; Former Senior Vice President and US Chief Compliance Officer, Privacy Officer and Senior Legal Counsel; Former Vice President, Ethics & Compliance Officer, TAP Pharmaceuticals, Boston, MA, USA![](https://internationalpharmacongress.com/wp-content/themes/ipc/faculty/perdomo_100.jpg)
Oscar Perdomo
Director, Pharmaceutical & Life Sciences, Advisory Services, PwC Switzerland, Zurich, Switzerland (Discussion Coordinator)MINI SUMMIT 12: GDPR and the Tumultuous World of Data Privacy
11:15 am CET
Introductions, Panel Discussion and Q&A![](https://internationalpharmacongress.com/wp-content/themes/ipc/faculty/biondi_100.jpg)
Stefano Biondi, LLB, PhD
Compliance Manager and Group Data Protection Officer, Menarini Group, Florence, Italy![](https://internationalpharmacongress.com/wp-content/themes/ipc/faculty/deville_100.jpg)
Rika De Ville
Vice President Global Compliance, Privacy & Data Protection Officer, Perrigo Company plc, Nazareth, Belgium![](https://internationalpharmacongress.com/wp-content/themes/ipc/faculty/quesada_100.jpg)
Ariadna Quesada, MSJ
Compliance Director Europe and MEATI, Hillrom; Former Law, Ethics and Compliance Officer, The Netherlands, AbbVie; Former Compliance Manager International, MicroPort Orthopedics, Amsterdam, Netherlands![](https://internationalpharmacongress.com/wp-content/themes/ipc/faculty/saporito_100.jpg)
Giuseppe Saporito, LLM
Global Legal & Regulatory Expert, IQVIA, Milan, Italy![](https://internationalpharmacongress.com/wp-content/themes/ipc/faculty/kohoutek_100.jpg)
Elisabeth Kohoutek
Senior Associate, FDA and Life Sciences, King & Spalding LLP, Frankfurt am Main, Germany (Discussion Coordinator)MINI SUMMIT 13: Ethics and Compliance Issues in Patient Relationships, Including Patient Access and Support
11:15 am CET
Introductions, Panel Discussion and Q&A![](https://internationalpharmacongress.com/wp-content/themes/ipc/faculty/beyazo_100.jpg)
Duygu Beyazo, LLB
Senior Associate, NSN Law Firm Former Compliance Manager (Secondment), Business Conduct, Gilead Sciences, Istanbul, Turkey![](https://internationalpharmacongress.com/wp-content/themes/ipc/faculty/eschbach_100.jpg)
Martin Eschbach, JD
Head Ethics, Risk and Compliance and Legal Patient Engagement, Novartis International AG, Baden-Württemberg, Germany![](https://internationalpharmacongress.com/wp-content/themes/ipc/faculty/jasnic_100.jpg)
Larisa K. Jasnic, LLB, LLM
Head of Ethics & Compliance, International, Alnylam Pharmaceuticals; Former Regional Compliance Officer, Region Europe, Novartis, Zug, Switzerland![](https://internationalpharmacongress.com/wp-content/themes/ipc/faculty/pepe_100.jpg)
Piergiorgio Pepe, MA
EU Law, President, Quantum Ethics; Ethics and Compliance Lecturer, SciencesPo; Board Member, Strategic Committee International Society of Healthcare Ethics and Compliance Professionals (ETHICS); Former Compliance Director Western Europe & Canada, AbbVie; Former Director, Compliance & Ethics EMEA, Bristol-Myers Squibb, Paris, France![](https://internationalpharmacongress.com/wp-content/themes/ipc/faculty/silver_100.jpg)
Paul Silver
Principal, Regulatory & Compliance Life Sciences Leader, Deloitte Advisory, Atlanta, GA, USA (Discussion Coordinator)12:15 pm CET
Luncheon Break/Visit Exhibit Hall
Day II Plenary Session
1:00 pm CET
Introduction to Global Anticorruption Landscape: Government Enforcement![](https://internationalpharmacongress.com/wp-content/themes/ipc/faculty/gregory_100.jpg)
Tom Gregory, MBA
Partner, Forensic & Integrity Services, EY, Atlanta, GA, USA (Session Moderator)1:05 pm CET
EU Public Prosecutor's Office (EPPO) Update![](https://internationalpharmacongress.com/wp-content/themes/ipc/faculty/krause-ablass_100.jpg)
Anna-Elisabeth Krause-Ablass, JD
European Delegated Prosecutor, European Public Prosecutor's Office; Former Specialized Public Prosecutor for White Collar Crime Frankfurt, Frankfurt, Germany![](https://internationalpharmacongress.com/wp-content/themes/ipc/faculty/dieners_100.jpg)
Peter Dieners, Esq.
Regional Managing Partner (Germany) and Head, Global Healthcare and Life Sciences Group, Clifford Chance; Member, Legal Affairs Focus Group and Compliance Network, MedTech Europe; Member, Legal Affairs Committee and Healthcare Compliance Committee, BVMed, Düsseldorf, Germany (Discussion Coordinator)1:25 pm CET
Agence Française Anti-corruption (AFA) Update![](https://internationalpharmacongress.com/wp-content/themes/ipc/faculty/grospiron_100.jpg)
Clément Grospiron
Mission Head to the Chief Supervision Directorate, Agence Française Anti-corruption (AFA), Paris, France![](https://internationalpharmacongress.com/wp-content/themes/ipc/faculty/fife_100.jpg)
George Fife
Partner, Forensic & Integrity Services, EY, Paris, France (Discussion Coordinator)1:45 pm CET
UK Serious Fraud Office Update![](https://internationalpharmacongress.com/wp-content/themes/ipc/faculty/krieg_100.jpg)
Judy Krieg, JD
Head of Fraud, Bribery and Corruption, Division B, UK Serious Fraud Office; Former Chief Compliance Officer, Rolls-Royce plc, London, UK2:05 pm CET
OECD Anti-bribery Update![](https://internationalpharmacongress.com/wp-content/themes/ipc/faculty/aiolfi_100.jpg)
Gemma Aiolfi
Head of Compliance, Corporate Governance and Collective Action, Basel, Switzerland2:35 pm CET
US FCPA and European Enforcement Update![](https://internationalpharmacongress.com/wp-content/themes/ipc/faculty/bonucci_100.jpg)
Nicola Bonucci, MA, DEA, DESS
Partner, Global Trade and Investigations & White Collar Defense, Paul, Hastings; Former Director of Legal Affairs, Organisation for Economic Cooperation and Development's (OECD), Paris, France![](https://internationalpharmacongress.com/wp-content/themes/ipc/faculty/fuhr_100.jpg)
David Fuhr, JD
Assistant Chief, FCPA Unit, Fraud Section, Criminal Division, US Department of Justice, Washington, DC, USA![](https://internationalpharmacongress.com/wp-content/themes/ipc/faculty/fusco_100.jpg)
Eugenio Fusco
Deputy Attorney at the Court, Public Prosecutor at the Court of Milan, Milan, Italy![](https://internationalpharmacongress.com/wp-content/themes/ipc/faculty/giampetruzzi_100.jpg)
Gary F. Giampetruzzi, JD
Partner, Paul Hastings; Former Vice President and Assistant General Counsel, Head of Government Investigations, Pfizer Inc., New York, NY, USA (Discussion Coordinator)3:15 pm CET
Transition Break3:30 pm CET
China Update![](https://internationalpharmacongress.com/wp-content/themes/ipc/faculty/li_100.jpg)
Lei Li, LLM
Managing Partner, Beijing and Shanghai Offices, Sidley Austin Former Third Secretary, Ministry of Commerce, People’s Republic of China, Beijing, China3:45 pm CET
LATAM Update![](https://internationalpharmacongress.com/wp-content/themes/ipc/faculty/alvarez_100.jpg)
Imelda Álvarez, LLB, MBA
Chief Executive Officer, Comply Latam, SC; Former Regional Integrity & Compliance Head Latin America and Canada, Novartis, Mexico City, Mexico4:00 pm CET
Global Anticorruption Roundtable![](https://internationalpharmacongress.com/wp-content/themes/ipc/faculty/alvarez_100.jpg)
Imelda Álvarez, LLB, MBA
Chief Executive Officer, Comply Latam, SC; Former Regional Integrity & Compliance Head Latin America and Canada, Novartis, Mexico City, Mexico![](https://internationalpharmacongress.com/wp-content/themes/ipc/faculty/dieners_100.jpg)
Peter Dieners, Esq.
Regional Managing Partner (Germany) and Head, Global Healthcare and Life Sciences Group, Clifford Chance; Member, Legal Affairs Focus Group and Compliance Network, MedTech Europe; Member, Legal Affairs Committee and Healthcare Compliance Committee, BVMed, Düsseldorf, Germany![](https://internationalpharmacongress.com/wp-content/themes/ipc/faculty/fife_100.jpg)
George Fife
Partner, Forensic & Integrity Services, EY, Paris, France![](https://internationalpharmacongress.com/wp-content/themes/ipc/faculty/gobena_100.jpg)
Gejaa T. Gobena, JD
Partner, Hogan Lovells; Former Deputy Chief, Fraud Section, Criminal Division; Former Trial Attorney, Civil Division, Fraud Section, US Department of Justice, Washington, DC, USA![](https://internationalpharmacongress.com/wp-content/themes/ipc/faculty/li_100.jpg)
Lei Li, LLM
Managing Partner, Beijing and Shanghai Offices, Sidley Austin Former Third Secretary, Ministry of Commerce, People’s Republic of China, Beijing, China![](https://internationalpharmacongress.com/wp-content/themes/ipc/faculty/gregory_100.jpg)